GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio
(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment. Read More